Ca2+ release through IP3R was shown to play an important role in melanoma CSCs, when the reduction of IP3R maturation after selenoprotein k (SELENOK) knockdown reduced Ca2+ release and led to a decrease in CD133+ populations [107]. The gene discussed is SELENOK; the disease is melanoma.